Upgrade to SI Premium - Free Trial

Theravance Biopharma (TBPH)

16.29 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/5/26)

Latest Headlines

Form 4 Theravance Biopharma, For: May 20 Filed by: Winningham Rick E May 22, 2026 6:28 PM - SEC Filing Form 4 Theravance Biopharma, For: May 20 Filed by: Sawaf Aziz May 22, 2026 6:25 PM - SEC Filing Form 4 Theravance Biopharma, For: May 20 Filed by: Miller Aine May 22, 2026 6:22 PM - SEC Filing Form 4 Theravance Biopharma, For: May 20 Filed by: Grimaud Brett A. May 22, 2026 6:20 PM - SEC Filing Form 4 Theravance Biopharma, For: May 20 Filed by: Farnum Rhonda May 22, 2026 6:18 PM - SEC Filing Form 10-Q Theravance Biopharma, For: Mar 31 May 7, 2026 9:01 AM - SEC Filing Form 8-K Theravance Biopharma, For: May 07 May 7, 2026 8:36 AM - SEC Filing Theravance Biopharma (TBPH) Misses Q1 EPS by 7c May 7, 2026 8:36 AM - StreetInsider Theravance Biopharma, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update May 7, 2026 8:30 AM - PR NewsWire Form DEF 14A Theravance Biopharma, For: Jun 12 April 28, 2026 5:00 PM - SEC Filing Theravance Biopharma (TBPH) PT Raised to $17 at B.Riley April 7, 2026 5:17 AM - StreetInsider Form 4 Theravance Biopharma, For: Apr 01 Filed by: Winningham Rick E April 3, 2026 6:10 PM - SEC Filing Form 4 Theravance Biopharma, For: Apr 01 Filed by: Sawaf Aziz April 3, 2026 6:08 PM - SEC Filing Form 4 Theravance Biopharma, For: Apr 01 Filed by: Grimaud Brett A. April 3, 2026 6:06 PM - SEC Filing Form 4 Theravance Biopharma, For: Apr 01 Filed by: Farnum Rhonda April 3, 2026 6:04 PM - SEC Filing Form 8-K Theravance Biopharma, For: Mar 27 March 30, 2026 5:40 PM - SEC Filing Form SCHEDULE 13D/A Theravance Biopharma, Filed by: Weiss Asset Management LP March 25, 2026 4:05 PM - SEC Filing Theravance Biopharma (TBPH) PT Raised to $15 at TD Cowen March 23, 2026 9:12 AM - StreetInsider Form 10-K Theravance Biopharma, For: Dec 31 March 23, 2026 8:47 AM - SEC Filing BTIG Reiterates Buy Rating on Theravance Biopharma (TBPH) amid Yupelri growth March 19, 2026 4:40 PM - StreetInsider Form 8-K Theravance Biopharma, For: Mar 19 March 19, 2026 8:38 AM - SEC Filing Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update March 19, 2026 8:30 AM - PR NewsWire Form 4 Theravance Biopharma, For: Mar 16 Filed by: Farnum Rhonda March 18, 2026 6:13 PM - SEC Filing Form 144 Theravance Biopharma, Filed by: Farnum Rhonda March 16, 2026 4:18 PM - SEC Filing Full Article List